# Caffeine Kinetics and CrossFit®-Specific Performance

> **NCT05516212** · PHASE2,PHASE3 · RECRUITING · sponsor: **Poznan University of Physical Education** · enrollment: 25 (estimated)

## Conditions studied

- Supplementation
- Sports Nutrition
- Ergogenic Support
- Discipline-specific Performance

## Interventions

- **DIETARY_SUPPLEMENT:** CAFMONO supplementation
- **DIETARY_SUPPLEMENT:** CAFMIPS_1 supplementation
- **DIETARY_SUPPLEMENT:** CAFMIPS_2 supplementation
- **DIETARY_SUPPLEMENT:** Placebo treatment

## Key facts

- **NCT ID:** NCT05516212
- **Lead sponsor:** Poznan University of Physical Education
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-29
- **Primary completion:** 2024-07-29
- **Final completion:** 2024-07-30
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2024-05-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05516212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05516212, "Caffeine Kinetics and CrossFit®-Specific Performance". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05516212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*